63 products were found matching your search for Antidepressant in 2 shops:

When we stop at the pharmacy to pick up our Prozac, are we simply buying a drug? Or are we buying into a disease as well? The first complete account of the phenomenon of antidepressants, this authoritative, highly readable book relates how depression, a disease only recently deemed too rare to merit study, has become one of the most common disorders of our day--and a booming business to boot.The Antidepressant Era chronicles the history of psychopharmacology from its inception with the discovery of chlorpromazine in 1951 to current battles over whether these powerful chemical compounds should replace psychotherapy. An expert in both the history and the science of neurochemistry and psychopharmacology, David Healy offers a close-up perspective on early research and clinical trials, the stumbling and successes that have made Prozac and Zoloft household names. The complex story he tells, against a backdrop of changing ideas about medicine, details the origins of the pharmaceutical industry, the pressures for regulation of drug companies, and the emergence of the idea of a depressive disease. This historical and neurochemical analysis leads to a clear look at what antidepressants reveal about both the workings of the brain and the sociology of drug marketing. Most arresting is Healy's insight into the marketing of antidepressants and the medicalization of the neuroses. Demonstrating that pharmaceutical companies are as much in the business of selling psychiatric diagnoses as of selling psychotropic drugs, he raises disturbing questions about how much of medical science is governed by financial interest.

This accessible volume offers a holistic exploration of this diverse class of drugs, from medical, historical, cultural, and economic perspectives.· Defines various forms of depression and explores the many types of medications used as antidepressants· Clearly explains how different medications affect the brain and how these neurochemical changes can lessen feelings of depression· Explores the history and evolution of antidepressant medications, as well as highlights current trends and speculates about future research directions· Delves into issues and controversies related to depression and its treatment, including overprescription and abuse of antidepressants, alternative and complementary therapies, and the stigma associated with mental illness

When we stop at the pharmacy to pick up our Prozac, are we simply buying a drug? Or are we buying into a disease as well? The first complete account of the phenomenon of antidepressants, this authoritative, highly readable book relates how depression, a disease only recently deemed too rare to merit study, has become one of the most common disorders of our day--and a booming business to boot. The Antidepressant Era chronicles the history of psychopharmacology from its inception with the discovery of chlorpromazine in 1951 to current battles over whether these powerful chemical compounds should replace psychotherapy. An expert in both the history and the science of neurochemistry and psychopharmacology, David Healy offers a close-up perspective on early research and clinical trials, the stumbling and successes that have made Prozac and Zoloft household names. The complex story he tells, against a backdrop of changing ideas about medicine, details the origins of the pharmaceutical industry, the pressures for regulation of drug companies, and the emergence of the idea of a depressive disease. This historical and neurochemical analysis leads to a clear look at what antidepressants reveal about both the workings of the brain and the sociology of drug marketing. Most arresting is Healy's insight into the marketing of antidepressants and the medicalization of the neuroses. Demonstrating that pharmaceutical companies are as much in the business of selling psychiatric diagnoses as of selling psychotropic drugs, he raises disturbing questions about how much of medical science is governed by financial interest.

When we stop at the pharmacy to pick up our Prozac, are we simply buying a drug? Or are we buying into a disease as well? The first complete account of the phenomenon of antidepressants, this authoritative, highly readable book relates how depression, a disease only recently deemed too rare to merit study, has become one of the most common disorders of our day--and a booming business to boot. The Antidepressant Era chronicles the history of psychopharmacology from its inception with the discovery of chlorpromazine in 1951 to current battles over whether these powerful chemical compounds should replace psychotherapy. An expert in both the history and the science of neurochemistry and psychopharmacology, David Healy offers a close-up perspective on early research and clinical trials, the stumbling and successes that have made Prozac and Zoloft household names. The complex story he tells, against a backdrop of changing ideas about medicine, details the origins of the pharmaceutical industry, the pressures for regulation of drug companies, and the emergence of the idea of a depressive disease. This historical and neurochemical analysis leads to a clear look at what antidepressants reveal about both the workings of the brain and the sociology of drug marketing. Most arresting is Healy's insight into the marketing of antidepressants and the medicalization of the neuroses. Demonstrating that pharmaceutical companies are as much in the business of selling psychiatric diagnoses as of selling psychotropic drugs, he raises disturbing questions about how much of medical science is governed by financial interest.

This accessible volume offers a holistic exploration of this diverse class of drugs, from medical, historical, cultural, and economic perspectives.· Defines various forms of depression and explores the many types of medications used as antidepressants· Clearly explains how different medications affect the brain and how these neurochemical changes can lessen feelings of depression· Explores the history and evolution of antidepressant medications, as well as highlights current trends and speculates about future research directions· Delves into issues and controversies related to depression and its treatment, including overprescription and abuse of antidepressants, alternative and complementary therapies, and the stigma associated with mental illness

Acceptable/Fair condition. Book is worn, but the pages are complete, and the text is legible. Has wear to binding and pages, may be ex-library. 2.2

An innovative, easily-accessible introduction to the subject for both clinicians and trainees. Illustrated throughout in colour, this handbook offers an invaluable visual lesson detailing data and information on all classes of antidepressants currently available.

Book is in Used-Good condition. Pages and cover are clean and intact. Used items may not include supplementary materials such as CDs or access codes. May show signs of minor shelf wear and contain limited notes and highlighting. 0.55

Stopping antidepressants can cause suicidal tendencies, while less severe reactions include aggression, dizziness, vomiting and headaches and even a mimicking of the symptoms of depression, confusing both doctor and patient and leading the patient to stay on medication longer than necessary. Here Joseph Glenmullen, Clinical Instructor in Psychiatry at Harvard Medical School, offers clear, effective and expert advice to help avoid the misuse of antidepressants, and to overcome withdrawal, dependence and addiction successfully and safely. It explains possible withdrawal symptoms. It identifies signs that a patient is ready to drop medication. It offers five-step programme for tapering off, which avoids unpleasant, dangerous after-effects. It contains checklists and charts to monitor symptoms and reactions. It features case studies throughout.

Unread book in perfect condition.

Book is in NEW condition. 0.55

“A carefully argued and convincing case.” ―Ann Levin, Associated PressDo antidepressants actually work, or are they just glorified dummy pills? How can we tell one way or the other?In Ordinarily Well, the celebrated psychiatrist and author Peter D. Kramer addresses the growing mistrust of antidepressants among the medical establishment and the broader public by taking the long view. He charts the history of the drugs’ development and the research that tests their worth, from the Swiss psychiatrist Roland Kuhn’s pioneering midcentury discovery of imipramine’s antidepressant properties to recent controversial studies suggesting that medications like Prozac and Paxil may be no better than placebos in alleviating symptoms. He unpacks the complex “inside baseball” of psychiatry―statistics―and reveals the fascinating ways that clinical studies and their results can be combined, manipulated, and skewed toward a desired conclusion. All the while, Kramer never loses sight of the patients themselves. He writes with deep empathy about his own clinical encounters over the decades as he weighed treatments, analyzed trial results, and considered the idiosyncrasies each case presented. As Kramer sees it, we must respect human complexity and the value of psychotherapy without denying the truth―that depression is a serious and destructive illness that demands the most effective treatment available.

Stopping antidepressants can cause suicidal tendencies, while less severe reactions include aggression, dizziness, vomiting and headaches and even a mimicking of the symptoms of depression, confusing both doctor and patient and leading the patient to stay on medication longer than necessary. Here Joseph Glenmullen, Clinical Instructor in Psychiatry at Harvard Medical School, offers clear, effective and expert advice to help avoid the misuse of antidepressants, and to overcome withdrawal, dependence and addiction successfully and safely. It explains possible withdrawal symptoms. It identifies signs that a patient is ready to drop medication. It offers five-step programme for tapering off, which avoids unpleasant, dangerous after-effects. It contains checklists and charts to monitor symptoms and reactions. It features case studies throughout.

Ship within 24hrs. Satisfaction 100% guaranteed. APO/FPO addresses supported

The second book in the Evidence-Based Guides series, The Evidence-Based Guide to Antidepressant Medications, provides a clear reference to the current knowledge and evidence base for the use of antidepressants among a variety of patients across a wide range of disorders. Today, in part due to the newer antidepressants, which have fewer side effects and less toxicity in overdose, many non mental health professionals feel comfortable prescribing antidepressants. Antidepressants are prescribed for many patients in addition to those who have major depressive disorder, including patients with bipolar disorder, posttraumatic stress disorder, schizophrenia, and personality disorders, as well as those with medical illnesses. In addition, antidepressants are increasingly being prescribed by clinicians for so-called off-label use to treat illnesses for which the medications do not have U.S. Food and Drug Administration (FDA) approval making it more important than ever for practicing clinicians to understand the use of antidepressants among several special populations, including children and adolescents, the geriatric patient, and pregnant and lactating women. Chapters within this guide are authored by experts in their respective areas of practice. Together, they have synthesized a large amount of medical literature into a comprehensive, yet understandable, concise, reader-friendly guide that features useful tables pertaining to the efficacy of specific medications and summaries of important clinical pearls of wisdom that are summarized at the end of each chapter into Key Clinical Concepts. This text is a must-have reference for psychiatrists and other practicing clinicians, residents-in-training, psychiatric nurses, social workers, and researchers.

Buy with confidence! Book is in new, never-used condition 1.03

Irving Kirsch has the world doubting the efficacy of antidepressants. Based on fifteen years of research, The Emperor's New Drugs makes an overwhelming case that what the medical community considered a cornerstone of psychiatric treatment is little more than a faulty consensus. But Kirsch does more than just criticize: He offers a path society can follow to stop popping pills and start proper treatment.

This spin-off from Stephen M. Stahl's new, completely revised, and fully updated sixth edition of the Prescriber's Guide covers the most important drugs in use today for treating depression. Now established as the indispensable formulary in psychopharmacology, easy to navigate and easy to use, the Prescriber's Guide combines evidence-based information with clinically informed guidance to support clinicians in making the most effective prescribing decisions for the good of their patients. Incorporating information on the newest indications, new formulations, new recommendations and new safety data, this edition continues to provide the essential practical support required by anyone prescribing in the field of mental health.

By the millennium Americans were spending more than 12 billion dollars yearly on antidepressant medications. Currently, millions of people in the U.S. routinely use these pills. Are these miracle drugs, quickly curing depression? Or is their popularity a sign that we now inappropriately redefine normal life problems as diseases? Are they prescribed too often or too seldom? How do they affect self-images? David Karp approaches these questions from the inside, having suffered from clinical depression for most of his adult life. In this book he explores the relationship between pills and personhood by listening to a group of experts who rarely get the chance to speak on the matter--those who are taking the medications. Their voices, extracted from interviews Karp conducted, color the pages with their experiences and reactions--humor, gratitude, frustration, hope, and puzzlement. Here, the patients themselves articulate their impressions of what drugs do to them and for them. They reflect on difficult issues, such as the process of becoming committed to medication, quandaries about personal authenticity, and relations with family and friends. The stories are honest and vivid, from a distraught teenager who shuns antidepressants while regularly using street drugs to a woman who still yearns for a spiritual solution to depression even after telling intimates "I'm on Prozac and it's saving me." The book provides unflinching portraits of people attempting to make sense of a process far more complex and mysterious than doctors or pharmaceutical companies generally admit.

This spin-off from Stephen M. Stahl's new, completely revised, and fully updated sixth edition of the Prescriber's Guide covers the most important drugs in use today for treating depression. Now established as the indispensable formulary in psychopharmacology, easy to navigate and easy to use, the Prescriber's Guide combines evidence-based information with clinically informed guidance to support clinicians in making the most effective prescribing decisions for the good of their patients. Incorporating information on the newest indications, new formulations, new recommendations and new safety data, this edition continues to provide the essential practical support required by anyone prescribing in the field of mental health.